Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 25

CN69 - Experiences of patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A qualitative study

Date

21 Oct 2023

Session

Poster session 25

Topics

Supportive Care and Symptom Management;  Cancer Research

Tumour Site

Gastric Cancer;  Colon and Rectal Cancer

Presenters

Jill Dobbelaer

Citation

Annals of Oncology (2023) 34 (suppl_2): S1229-S1256. 10.1016/annonc/annonc1321

Authors

J. Dobbelaer1, W. Ceelen2, E. Pape3, S. De Meyer2, S. Cosyns4

Author affiliations

  • 1 Digestive Oncology, UZ Gent - University Hospital Ghent, 9000 - Gent/BE
  • 2 Gastro-intestinal Surgery, UZ Gent - University Hospital Ghent, 9000 - Gent/BE
  • 3 Oncology, UZ Gent - Universitair Ziekenhuis Gent, 9000 - Gent/BE
  • 4 Experimental Surgery, Ghent University - University Centre for Nursing and Midwifery, 9000 - Ghent/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN69

Background

Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) can control the disease state of patients with limited peritoneal carcinomatosis (PC). In spite of the fact that it is an effective and promising treatment, it has a big impact on various aspects of patients’ quality of life. The aim of this study is to explore experiences and needs of patients with digestive tumors after CRS/HIPEC (short and long-term).

Methods

An explorative qualitative design was used. Individual semi-structured interviews were performed with 15 patients (2-14 months postoperatively) between December 2020 and May 2021 in one expert university hospital in Belgium. Data-analysis was done using thematic analysis and investigators’ triangulation was used.

Results

Before surgery, patients relied on the expertise of the surgeon and saw the surgery as their only hope. After surgery, patients underestimated rehabilitation due to acute and long-term effects of the treatment. They described their relatives as a second victim but experienced their support at the same time. Patients were grateful for the future but also had fear for recurrence. Treatment by an experienced surgeon and the counseling of a clinical nurse specialist was seen as an added value. The need for contact with peers varied among patients.

Conclusions

CRS/HIPEC has a large impact on patients’ and their relatives’ lives. Patients were confronted with short and long-term effects. The healthcare professionals (HCPs) should adapt the amount and kind of information before surgery to the coping mechanism of the patient. Counseling afterwards is necessary. HCPs should pay attention to the needs of the relatives as well and explore if the patients have a need to meet with peers.

Clinical trial identification

B6702020000805.

Editorial acknowledgement

Legal entity responsible for the study

Department of Gastrointestinal Surgery.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.